Patient compliance in type 2 DM best with glipizide GITS

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.379, 2002-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A ‘Real-World’ Analysis of Persistence on and Adherence to Glipizide GITS, Glipizide IR and Glibenclamide in Managed Care among Patients with Type 2 Diabetes Mellitus

By Harley C.R.  

Clinical Drug Investigation, Vol. 22, Iss. 9, 2002-01 ,pp. : 575-584

Adis International

Access to resources Recommend Favorite

Lifestyle modification best option for preventing type 2 DM

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 474, 2005-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Patient Compliance and Persistence with Anti-hyperglycemic Therapy: Evaluation of a Population of Type 2 Diabetic Patients

By Dailey G   Kim MS   Lian JF  

The Journal of International Medical Research, Vol. 30, Iss. 1, 2002-01 ,pp. : 71-79

Field House Publishing

Access to resources Recommend Favorite

Insulin aspart: Type 2 diabetes mellitus following administration via SC infusion pump in a patient with T1DM: case report

By  

Reactions Weekly, Vol. 1, Iss. 1198, 2008-01 ,pp. : 27-27

Adis International

Access to resources Recommend Favorite

Glipizide: A Review of the Pharmacoeconomic Implications of the Extended-Release Formulation in Type 2 Diabetes Mellitus

By Foster R.H.   Plosker G.L.  

PharmacoEconomics, Vol. 18, Iss. 3, 2000-09 ,pp. : 289-306

Adis International

Access to resources Recommend Favorite